We must differentiate between primary iron overload, and iron overload that accompanies ineffective erythropoiesis: in the latter case the administration of hepcidin might be considered as a new potential therapeutic approach to reduce iron overload in thalassemias and other forms of anemia associated with ineffective erythropoiesis [33]. Here, HAMP is linked to anemia (phenotype).